FDA Center for Drug Evaluation & Research Issues Warning Letter to PolleyMed
May 20, 2026
May 20, 2026
WASHINGTON, May 20 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to PolleyMed LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: John W. Polley, MD, PolleyMed, LLC, 1248 Hastings Street, Traverse City, MI 49686, United States, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
To Dr. . . .
* * *
Recipient: John W. Polley, MD, PolleyMed, LLC, 1248 Hastings Street, Traverse City, MI 49686, United States, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
To Dr. . . .